December 1, 2020 | 6:00-7:00 PM Eastern Time

CME Information: 1.0 credit

Speakers: Susheel Kodali, MD, and Rebecca Hahn, MD, FASE

Panelists: Nishath Quader, MD, FASE, and G. Burkhard Mackensen, MD, PhD, FASE

Join Rebecca Hahn, MD, FASE, Susheel Kodali, MD, G. Burkhard Mackensen, MD, PhD, FASE, and Nishath Quader, MD, FASE, for a live interactive Webinar on December 1st at 6:00-7:00 PM ET as they discuss “Management of Concomitant Mitral and Tricuspid Valve Regurgitation: Procedural and Imaging Considerations". This webinar is hosted by ASE's Interventional Echocardiography Specialty Interest Group. With the rise of percutaneous technologies for treatment of valvular heart disease, there has also been an increasing push to standardize echocardiographic imaging and to also ensure that echocardiographers are educated on these technologies. It is also imperative that interventional echocardiographers learn effective communication with the proceduralists. This live webinar will illustrate the treatment options available for concomitant mitral and tricuspid valve disease. 

With the rise of percutaneous technologies for treatment of valvular heart disease, there has also been an increasing push to standardize echocardiographic imaging and to also ensure that echocardiographers are educated on these technologies. It is also imperative that interventional echocardiographers learn effective communication with the proceduralists. The purpose of this one-hour webinar would be to illustrate the treatment options available for concomitant mitral and tricuspid valve disease. We will discuss the patient scenario, treatment options, echocardiographic images at baseline. The speakers are an interventional cardiologist and an interventional echocardiographer who will discuss percutaneous management of the disease with focus of pre-procedural TEE imaging and also intra-procedural imaging. The goal of this webinar is to demonstrate a multidisciplinary heart team approach to evaluate and treat complex patients with valvular heart disease with a special focus on imaging. 

Target Audience: This activity is designed for all cardiovascular sonographers and physicians with a primary interest and knowledge base in the field of cardiovascular imaging.

Learning Objectives:

1. Discuss treatment options for concomitant MR/TR
2. Discuss in detail pre-procedural images required to assess for percutaneous treatment candidacy
3. Discuss intra-procedure imaging of mitral and tricuspid valve along with heavy focus on 3D image guidance of percutaneous procedures
4. Discuss post procedure quantification of valve regurgitation along with post procedure imaging considerations.
5. Illustrate effective intraprocedural communication between the interventional echocardiographer and proceduralist

Accreditation Statement:

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this activity for a maximum of 1 hour of AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine’s Maintenance of Certification (MOC) program.

ARDMS, CCI, Sonography Canada recognize ASE’s certificates and have agreed to honor the credit hours toward their registry requirements for sonographers.

Disclosures: 

According to ACCME policy, ASE implemented mechanisms to resolve all conflicts of interest prior to the planning and implementation of this activity.

The following speakers/moderators reported relationships with one or more commercial interests:

• Rebecca Hahn, MD, FASE

       Edwards Lifescience - (Consultant, Advisor, SAB), Medtronic - (Consultant, Advisor), Abbott -       (SAB), Navigate - (Equity), Philips Healthcare - (Consultant, Advisor)

• Susheel Kodali, MD

       Claret Medical - (Consultant, Advisor), Abbot Vascular - (Consultant, Advisor), Meril LIfesciences         - (Consultant, Advisor), Admedus - (Consultant, Advisor), Thubrikar Aortic Valve, Inc. - (SAB),      Dura Biotech - (SAB), Biotrace Medical - (SAB), MID - (SAB). 

The following speakers/moderators reported no disclosures or relationships with commercial interests:

• Nishath Quader, MD, FASE
• G. Burkhard Mackensen, MD, PhD, FASE

The following CME reviewers and ASE Staff reported no actual or potential conflicts of interest in relation to this document: 

• Kathryn Lyons, ASE Medical Education Manager
• Ratna Vadlamundi, MD, FASE
• Anita Wokhlu, MD, FASE

• Contact:
  ASE Learning Hub